Vertex Pharmaceuticals files automatic mixed securities shelf
EST Vertex Pharmaceuticals (VRTX) files automatic mixed securities shelfMaximize Your Portfolio with Data Driven Insights:Leverage the ...
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
News Medical2d
New insights could help prevent peripheral neuropathy or slow disease onset
An increase in high-fat, high-fructose foods in people's diets has contributed to a dramatic increase in type 2 diabetes.
CLM Platform Spotdraft Announces $54 Series B Funding Round
The contract lifecycle management platform aims to spend this year focusing on growing its talent and continuing to expand AI ...
SpotDraft Secures $54 Million To Lead AI Contract Lifecycle Management
SpotDraft's Series B funding round, spearheaded by Vertex Ventures and Trident Partners, will accelerate the company's global ...
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
Shares of Vertex Pharmaceuticals Inc. VRTX slipped 3.14% to $455.22 Tuesday, on what proved to be an all-around favorable ...
Chemistry World4d
New type of painkiller approved in US
For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).